Clinical Trial Update: Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating progesterone to prevent miscarriage and preterm birth in women with first-trimester bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage
• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Miscarriage, Preterm Birth | Phase 2 | Status: COMPLETED